BT and TalkTalk’s appeal against telecom regulator Ofcom’s ruling on superfast broadband charges has now been referred to the Competition and Markets Authority (CMA).
Ofcom’s ruling in March came amid complaints from TalkTalk and other rivals that BT was offering substantially lower retail prices and much higher wholesale prices, thus improving its dominant position in the market while potentially squeezing out competition.
While Ofcom has recently admitted it is looking at various options for the company, which include the “structural separation” of Openreach from BT, it has largely played down fears relating to lack of competition from rivals.
But nevertheless its subsequent price ruling is geared to ensuring BT keeps offering a substantially lower price to rivals for wholesale superfast broadband charges, allowing them to profitably match prices.
As the former state incumbent, BT is currently the largest retail provider of fibre broadband services over its Openreach network, although it is still required to allow other operators to use the same infrastructure to sell superfast broadband to consumers.
The regulator’s new rule does also aim to preserve BT’s current flexibility to set its wholesale fibre prices without doing it in such a way that prevents other firms competing.
Full content: The Register
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas